Delivery Order SPE2DB22D3501-SPE2DB25FWX64
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Nateglinide 60 mg tablets (100-count units) with a ceiling value of $1,554.62. This firm fixed-price delivery order, which has a completion date of September 10, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading pharmaceutical distributors and serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,475.49 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) under a firm fixed price contract. The award was issued on June 26, 2025, with an ultimate completion date of June 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a routine pharmaceutical procurement action within the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,694.90 to AmerisourceBergen Drug Corp for 100 tablets of Nateglinide 60 mg, an oral antidiabetic medication. This competitive, non-set-aside delivery order, effective through September 18, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location under firm fixed price terms. The award represents a child contract action under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,079.18 to supply Nateglinide 120 mg tablets (100-count units) under a firm fixed price contract with an ultimate completion date of July 29, 2025. This non-set-aside award was competitively procured and represents a child contract action originating from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Nateglinide 60 mg tablets in quantities of 100 units, with a contract ceiling value of $6,925.84 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Nateglinide is...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,435 to Amerisourcebergen Drug Corporation to supply 120 mg tablets of nateglinide in unit doses of 30 tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 8-11, 2023. This delivery order was issued against an existing DLA contract vehicle to support the agency's medical supply needs, but no additional...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,634.67 firm-fixed-price contract is for the delivery of Nateglinide 60 mg tablets, a type of oral antidiabetic medication. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $837 to Amerisourcebergen Drug Corporation for the supply of 30 boxes of 60mg Nateglinide tablets. Performance will take place in Conshohocken, Pennsylvania over a two day period in early August 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its Corporate Office Division location. No major subcontractors or set aside designations were indicated. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nateglinide 60 mg tablets. The contract has a ceiling value of $4,166.99 and runs through April 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency Troop Support Medical awarded a $427,640 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561322346 Nateglinide 120 mg tablets packaged in quantities of 100 tablets. The place of performance for the contract is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from June 23, 2023 through June 26, 2023. No subcontractors or set aside designations were identified. The Defense...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWX64Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,181.29 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The delivery order for Nateglinide, an antidiabetic medication, supports DLA's medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/18/25 |